Core Insights - The successful completion of Switzerland's first endovascular reconstruction surgery using the CS integrated arch three-branch reconstruction system marks a significant achievement in the field of aortic arch treatment, showcasing the advanced technology and clinical value of Chinese innovations in Europe [1][2][9] Group 1: Technology and Innovation - The CS integrated arch three-branch reconstruction system, developed by Professor Shu Chang and Xianjian Technology, addresses multiple technical challenges in endovascular treatment of aortic arch diseases through its unique integrated design [2][3] - The system features a unique groove structure that enhances surgical safety and simplifies the procedure, reducing operational difficulty and minimizing the risk of cerebral ischemia [2][3] - The system has completed First in Man (FIM) studies in China and is progressing with multi-center registration clinical trials [2] Group 2: Clinical Application and Challenges - The surgery addressed a complex aortic arch aneurysm involving the left subclavian artery and descending aorta, presenting significant challenges due to the patient's anatomical structure [3][6] - The procedure demonstrated successful outcomes with no stent migration or leakage, achieving ideal isolation and blood supply reconstruction [6][8] - The CS system provides a systematic and minimally invasive solution for complex aortic arch diseases, enhancing the safety and effectiveness of treatments [6][9] Group 3: International Collaboration and Education - Following the successful surgery in Switzerland, Professor Shu Chang conducted technical training and academic exchanges in Kazakhstan, performing multiple complex aortic repairs [8][9] - The introduction of various innovative surgical techniques in Kazakhstan highlights the adaptability and effectiveness of Chinese solutions in addressing complex vascular conditions [7][8] - The collaboration between Chinese experts and international medical centers emphasizes the global impact of Chinese medical innovations and the importance of knowledge sharing in advancing aortic disease treatment [9]